Wealth Enhancement Advisory Services LLC Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Wealth Enhancement Advisory Services LLC lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 222.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 38,786 shares of the medical instruments supplier's stock after acquiring an additional 26,748 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in DENTSPLY SIRONA were worth $736,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in XRAY. Vise Technologies Inc. acquired a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $195,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in DENTSPLY SIRONA by 13.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier's stock valued at $10,466,000 after buying an additional 65,308 shares during the period. Voloridge Investment Management LLC bought a new stake in DENTSPLY SIRONA during the fourth quarter worth about $24,571,000. Tidal Investments LLC lifted its stake in shares of DENTSPLY SIRONA by 15.5% in the 4th quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier's stock valued at $488,000 after acquiring an additional 3,449 shares during the last quarter. Finally, True Wealth Design LLC raised its position in DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after purchasing an additional 1,950 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on XRAY. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a research report on Tuesday, April 15th. Piper Sandler cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Barrington Research increased their price target on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Finally, UBS Group reduced their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Eleven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.36.

DENTSPLY SIRONA Trading Down 2.4%

NASDAQ XRAY traded down $0.38 during trading on Friday, reaching $15.63. 1,408,937 shares of the stock traded hands, compared to its average volume of 2,971,156. The firm has a market cap of $3.11 billion, a price-to-earnings ratio of -7.55, a price-to-earnings-growth ratio of 1.80 and a beta of 0.95. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.95. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock's 50-day moving average price is $14.85 and its 200 day moving average price is $16.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. During the same quarter last year, the company posted $0.42 earnings per share. The company's revenue for the quarter was down 7.8% compared to the same quarter last year. Analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a $0.16 dividend. The ex-dividend date is Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 4.09%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.